CARIBOU BIOSCIENCES, INC. : LEERINK PARTNERS CUTS TO MARKET PERFORM FROM OUTPERFORM; CUTS TARGET PRICE TO $1 FROM $4

Reuters · 2d ago

Please log in to view news